Glaxo fined $3bn over US health fraud

Drugs firm GlaxoSmithKline will pay $3bn (€2.4bn) in fines after admitting to the largest healthcare fraud in US history.

Glaxo fined $3bn over US health fraud

Drugs firm GlaxoSmithKline will pay $3bn (€2.4bn) in fines after admitting to the largest healthcare fraud in US history.

The UK’s largest pharmaceutical company was accused of bribing doctors in America to prescribe medicines for unapproved uses, with potentially dangerous side effects.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €130 €65

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited